We are honored that some of the most respected and influential international scientists in the field, together with representatives of central stakeholders, have committed themselves to serve on this board. The board members will give advice on proposed scientific directions, help set long term goals and strategies, and make independent assessment of research progress. Importantly, the board will provide access to an expanded global network both for facilitating research and for its implementation into policies.
Peter Ulleryd, Deputy Infection Control Practitioner at VGR, previously at WHO Antimicrobial Drug Resistance Team, Sweden
Ramanan Laxminarayan, Director of the center for Disease Dynamics, Economics & Policy, USA
Gerry Wright, McMaster University, Canada
Jason Snape, Newcastle University and AstraZeneca, UK
Michael Selgelid, Monash University, Australia
Johan Struwe, Public Health Agency of Sweden, previously at WHO Antimicrobial Drug Resistance Team, Sweden
Amy Pruden, Virginia Tech University, USA